Antibiotics | Escherichia coli (n = 81) | Klebsiella pneumoniae (n = 40) | ||||
---|---|---|---|---|---|---|
Nosocomial (n = 32) | Community-acquired (n = 49) | p value | Nosocomial (n = 14) | Community-acquired (n = 26) | p value | |
ESBL | 25 (78.1) | 15 (30.6) | 0.000 | 4 (28.6) | 2 (7.7) | 0.194 |
Ampicillin | 29 (90.6) | 43 (87.8) | 0.968 | 14 (100) | 24 (92.3) | 0.533 |
Piperacillin | 28 (87.5) | 37 (75.5) | 0.299 | 6 (42.9) | 3 (11.5) | 0.062 |
Amoxicillin-clavulanic acid | 12 (37.5) | 10 (20.4) | 0.091 | 3 (21.4) | 1 (3.8) | 0.224 |
Piperacillin/tazobactam | 4 (12.5) | 0 | 0.022 | 2 (14.3) | 0 | 0.117 |
Cefazolin | 26 (81.2) | 13 (26.5) | 0.000 | 4 (28.6) | 4 (15.4) | 0.562 |
Ceftazidime | 25 (78.1) | 13 (26.5) | 0.000 | 4 (28.6) | 2 (7.7) | 0.194 |
Cefotaxime | 27 (84.3) | 15 (30.6) | 0.000 | 4 (28.6) | 2 (7.7) | 0.194 |
Cefepime | 23 (71.9) | 11 (22.4) | 0.000 | 4 (28.6) | 0 | 0.011 |
Aztreonam | 18 (56.3) | 10 (20.4) | 0.001 | 2 (14.3) | 1 (3.8) | 0.571 |
Imipenem | 2 (6.3) | 0 | 0.153 | 2 (14.3) | 0 | 0.117 |
Meropenem | 1 (3.1) | 0 | 0.395 | 1 (7.1) | 0 | 0.350 |
Amikacin | 2 (6.3) | 0 | 0.153 | 1 (7.1) | 0 | 0.350 |
Levofloxacin | 23 (71.9) | 21 (42.9) | 0.01 | 3 (21.4) | 1 (3.8) | 0.224 |
SMZ | 21 (65.6) | 30 (61.2) | 0.688 | 3 (21.4) | 4 (15.4) | 0.965 |
Gentamicin | 17 (53.1) | 25 (51.0) | 0.853 | 2 (14.3) | 2 (7.7) | 0.912 |
Tetracycline | 25 (78.1) | 39 (79.6) | 0.874 | 4 (28.6) | 4 (15.4) | 0.562 |